XML 37 R27.htm IDEA: XBRL DOCUMENT v3.7.0.1
Fair Value Measurements (Tables)
3 Months Ended
Mar. 31, 2017
Fair Value Disclosures [Abstract]  
Schedule of financial assets and liabilities carried at fair value on a recurring basis
The following tables present the Company’s financial assets and liabilities carried at fair value on a recurring basis by fair value hierarchy category:

Assets and liabilities measured at
fair value on a recurring basis
 
March 31, 2017
 
Quoted prices
 
Significant
 
 
 
 
 
in active
markets for
identical assets
(Level 1)
 
other
observable
inputs
(Level 2)
 
Significant
unobservable
inputs
(Level 3)
 
Total
Assets
 

 
 

 
 

 
 

Fixed maturities available-for-sale:
 

 
 

 
 

 
 

U.S. government direct obligations and U.S. agencies
$


$
1,840,368


$


$
1,840,368

Obligations of U.S. states and their subdivisions


2,100,099




2,100,099

Corporate debt securities


14,542,646


10,931


14,553,577

Asset-backed securities


1,528,264




1,528,264

Residential mortgage-backed securities


127,726




127,726

Commercial mortgage-backed securities


1,358,065




1,358,065

Collateralized debt obligations


534,237




534,237

Total fixed maturities available-for-sale


22,031,405


10,931


22,042,336

Fixed maturities held-for-trading:
 


 


 


 

U.S. government direct obligations and U.S. agencies


129,296




129,296

Corporate debt securities


55,249




55,249

Commercial mortgage-backed securities


1,072




1,072

Total fixed maturities held-for-trading


185,617




185,617

Short-term investments
262,866


481,197




744,063

Collateral under securities lending agreements
94,531






94,531

Collateral under derivative counterparty collateral agreements
80,145






80,145

Derivative instruments designated as hedges:
 


 


 


 

Interest rate swaps


37,308




37,308

Cross-currency swaps

 
43,652

 

 
43,652

Derivative instruments not designated as hedges:
 


 


 


 

Interest rate swaps


8,187




8,187

Interest rate swaptions


265




265

Other forward contracts


7,817




7,817

Cross-currency swaps


42,071




42,071

Total derivative instruments


139,300




139,300

Separate account assets (1)
15,849,064


11,330,972




27,597,906

Total assets
$
16,286,606


$
34,168,491


$
10,931


$
50,883,898

 











Liabilities
 


 


 


 

Payable under securities lending agreements
$
94,531


$


$


$
94,531

Collateral under derivative counterparty collateral agreements
80,145

 

 

 
80,145

Derivative instruments designated as hedges:
 


 


 


 

Cross-currency swaps


10,921




10,921

Derivative instruments not designated as hedges:
 


 


 


 

Interest rate swaps


14,895




14,895

Other forward contracts


1,033




1,033

Cross-currency swaps


22,919




22,919

Total derivative instruments


49,768




49,768

Embedded derivatives - GLWB

 

 
4,042

 
4,042

Separate account liabilities (2)
26


409,044




409,070

Total liabilities
$
174,702


$
458,812


$
4,042


$
637,556


(1) Included in the total fair value amount are $418 million of investments as of March 31, 2017 for which the fair value is estimated using net asset value per unit as a practical expedient which are excluded from the disclosure requirement to classify amounts in the fair value hierarchy in connection with the adoption of ASU 2015-07.
 (2) Includes only separate account instruments which are carried at the fair value of the underlying liabilities owned by the separate accounts.

Assets and liabilities measured at
fair value on a recurring basis
 
December 31, 2016
 
Quoted prices
 
Significant
 
 
 
 
 
in active
markets for
identical assets
(Level 1)
 
other
observable
inputs
(Level 2)
 
Significant
unobservable
inputs
(Level 3)
 
Total
Assets
 


 


 


 

Fixed maturities available-for-sale:
 


 


 


 

U.S. government direct obligations and U.S. agencies
$


$
3,035,112


$


$
3,035,112

Obligations of U.S. states and their subdivisions


2,098,662




2,098,662

Corporate debt securities


13,968,110


11,639


13,979,749

Asset-backed securities


1,312,379




1,312,379

Residential mortgage-backed securities


140,992




140,992

Commercial mortgage-backed securities


1,225,282




1,225,282

Collateralized debt obligations


361,527




361,527

Total fixed maturities available-for-sale


22,142,064


11,639


22,153,703

Fixed maturities held-for-trading:
 


 


 


 

U.S. government direct obligations and U.S. agencies


458,067




458,067

Corporate debt securities


55,591




55,591

Commercial mortgage-backed securities


1,080




1,080

Total fixed maturities held-for-trading


514,738




514,738

Short-term investments
267,851


36,137




303,988

Collateral under derivative counterparty collateral agreements
103,214






103,214

Derivative instruments designated as hedges:
 


 


 


 

Interest rate swaps


33,390




33,390

Cross-currency swaps

 
53,641

 

 
53,641

Derivative instruments not designated as hedges:
 


 


 


 

Interest rate swaps


8,982




8,982

Interest rate swaptions


354




354

Cross-currency swaps


50,018




50,018

Total derivative instruments


146,385




146,385

Separate account assets (1)
15,407,992


11,199,924




27,037,765

Total assets
$
15,779,057


$
34,039,248


$
11,639


$
50,259,793

 











Liabilities
 


 


 


 

Collateral under derivative counterparty collateral agreements
$
103,214

 
$

 
$

 
$
103,214

Derivative instruments designated as hedges:
 


 


 


 

Cross-currency swaps


8,294




8,294

Derivative instruments not designated as hedges:
 


 


 


 

Interest rate swaps


13,340




13,340

Cross-currency swaps


16,647




16,647

Total derivative instruments


38,281




38,281

Embedded derivatives - GLWB

 

 
5,712

 
5,712

Separate account liabilities (2)
55


336,468




336,523

Total liabilities
$
103,269


$
374,749


$
5,712


$
483,730


(1) Included in the total fair value amount are $430 million of investments as of December 31, 2016 for which the fair value is estimated using net asset value per unit as a practical expedient which are excluded from the disclosure requirement to classify amounts in the fair value hierarchy in connection with the adoption of ASU 2015-07.
 (2) Includes only separate account instruments which are carried at the fair value of the underlying liabilities owned by the separate accounts.

Schedule of assets and liabilities measured at fair value on a recurring basis, for which Level 3 inputs are utilized to determine fair value
The following tables present additional information about assets and liabilities measured at fair value on a recurring basis and for which the Company has utilized Level 3 inputs to determine fair value:
 
Recurring Level 3 financial assets and liabilities

Three Months Ended March 31, 2017
 
Assets
 
Liabilities
 
Fixed maturities  available-for-sale
 
Embedded
 
Corporate
 
derivatives
 
debt securities
 
- GLWB
Balances, January 1, 2017
$
11,639


$
5,712

Realized and unrealized gains (losses) included in:
 


 
Net income (loss)

 
1,670

Other comprehensive income (loss)
(364
)


Settlements
(344
)


Balances, March 31, 2017
$
10,931


$
4,042

Total gains (losses) for the period included in net income attributable to the change in unrealized gains and losses relating to assets and liabilities held at March 31, 2017
$


$
1,670



Recurring Level 3 financial assets and liabilities

Three Months Ended March 31, 2016
 
Assets
 
Liabilities
 
Fixed maturities 
available-for-sale
 
Embedded
 
Corporate
 
derivatives
 
debt securities
 
- GLWB
Balances, January 1, 2016
$
4,538


$
11,257

Realized and unrealized gains (losses) included in:
 


 
Net income (loss)

 
(10,450
)
Other comprehensive income (loss)
366



Settlements
(598
)


Transfers into Level 3 (1)
11,236

 

Balances, March 31, 2016
$
15,542


$
21,707

Total gains (losses) for the period included in net income attributable to the change in unrealized gains and losses relating to assets and liabilities held at March 31, 2016
$


$
(10,450
)

 (1) Transfers into Level 3 are due primarily to decreased observability of inputs in valuation methodologies.

Schedule of significant unobservable inputs used during the valuation of liabilities categorized within Level 3 of the recurring fair value measurements table
The following table presents significant unobservable inputs used during the valuation of certain liabilities categorized within Level 3 of the recurring fair value measurements table:
 
 
 
 
 
 
Range
 
 
Valuation Technique
 
Unobservable Input
 
March 31, 2017
 
December 31, 2016
Embedded derivatives - GLWB
 
Risk neutral stochastic valuation methodology
 
Equity volatility
 
15% - 28%
 
15% - 30%
 
 
 
 
Swap curve
 
1.38% - 2.66%
 
0.75% - 3.00%
 
 
 
 
Mortality rate
 
Based on the Annuity 2000 Mortality Table
 
Based on the Annuity 2000 Mortality Table
 
 
 
 
Base Lapse rate
 
1% - 15%
 
1% - 15%
Summary of the carrying amounts and estimated fair values of financial instruments not carried at fair value on a recurring basis
The following tables summarize the carrying amounts and estimated fair values of the Company’s financial instruments and investments not carried at fair value on a recurring basis:
 
March 31, 2017
 
December 31, 2016
 
Carrying
 
Estimated
 
Carrying
 
Estimated
 
amount
 
fair value
 
amount
 
fair value
Assets
 

 
 

 
 

 
 

Mortgage loans on real estate
$
3,844,931

 
$
3,915,687

 
$
3,558,826

 
$
3,574,240

Policy loans
4,016,844

 
4,016,844

 
4,019,648

 
4,019,648

Limited partnership interests
32,579

 
31,947

 
29,345

 
29,822

Other investments
13,935

 
44,243

 
14,382

 
44,687

 
 
 
 
 
 
 
 
Liabilities
 

 
 

 
 

 
 

Annuity contract benefits without life contingencies
$
12,383,984

 
$
12,249,498

 
$
12,291,378

 
$
12,129,631

Policyholders’ funds
241,167

 
241,167

 
285,554

 
285,554

Commercial paper
98,645

 
98,645

 
99,049

 
99,049

Notes payable
534,339

 
528,415

 
531,092

 
495,004